Mylan, Ranbaxy Urge Stay Of Provigil Pay-For-Delay Suits
Mylan Inc. and Ranbaxy Laboratories Ltd. on Thursday urged a Pennsylvania federal judge to stay three cases accusing them and others of accepting $300 million from Cephalon Inc. to delay generic versions...To view the full article, register now.
Already a subscriber? Click here to view full article